Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Prior Information Notice

Clinical Trial Manufacturing and Distribution Services

  • First published: 11 May 2024
  • Last modified: 11 May 2024

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-0458a3
Published by:
Nottingham Trent University (NTU)
Authority ID:
AA83233
Publication date:
11 May 2024
Deadline date:
-
Notice type:
Prior Information Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.

Full notice text

Prior information notice

This notice aims at reducing time limits for receipt of tenders

Section I: Contracting authority

I.1) Name and addresses

Nottingham Trent University (NTU)

GB 277399933

50 Shakespeare Street

Nottingham

NG1 4FQ

UK

Contact person: Mark Lucas

Telephone: +44 1158488747

E-mail: mark.lucas@ntu.ac.uk

NUTS: UKF14

Internet address(es)

Main address: https://www.ntu.ac.uk/

Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.3) Communication

Access to the procurement documents is restricted. Further information can be obtained at:

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=81558&B=NTU


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=81558&B=NTU


Tenders or requests to participate must be sent to the abovementioned address


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Education

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Clinical Trial Manufacturing and Distribution Services

Reference number: NTU/24/2615/ML

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.

II.1.5) Estimated total value

Value excluding VAT: 344 676.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

33600000

II.2.3) Place of performance

NUTS code:

UKF14


Main site or place of performance:

England and Wales

II.2.4) Description of the procurement

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6) Estimated value

Value excluding VAT: 344 676.00  GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.3) Estimated date of publication of contract notice:

17/06/2024

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:

Suitably regulated, accredited and licensed suppliers

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


III.2) Conditions related to the contract

III.2.2) Contract performance conditions

TBC

III.2.3) Information about staff responsible for the performance of the contract

Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract

Section IV: Procedure

IV.1) Description

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section VI: Complementary information

VI.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

VI.4) Procedures for review

VI.4.1) Review body

Royal Courts of Justice

Strand

London

WC2A 2LL

UK

VI.4.2) Body responsible for mediation procedures

The Royal Courts of Justice

Strand

London

WC2A 2LL

UK

VI.4.4) Service from which information about the review procedure may be obtained

Royal Courts of Justice

Strand

London

WC2A 2LL

UK

VI.5) Date of dispatch of this notice

10/05/2024

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
mark.lucas@ntu.ac.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.